Accelerate Diagnostics to Review Second Quarter 2018 Results on August 6th
July 19, 2018 14:30 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., July 19, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Monday, August 6, 2018 to review the company’s second quarter 2018...
Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
June 05, 2018 11:30 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., June 05, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the William Blair...
Accelerate Diagnostics reports Q1 2018 financial results
May 09, 2018 16:03 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 09, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up...
Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th
April 30, 2018 10:42 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 30, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 9, 2018 to review its first quarter 2018 financial...
Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
April 21, 2018 03:37 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 21, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the sizeable release of new data presented by the company, its customers, and clinical experts during...
Accelerate Diagnostics, Inc. Announces Pricing of $150 Million Convertible Notes Offering
March 23, 2018 02:15 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., March 23, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate Diagnostics”) (NASDAQ:AXDX) today announced the pricing of $150.0 million aggregate principal amount of...
Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering
March 22, 2018 07:08 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced its intention to offer, subject to market conditions and other factors, $150.0 million...
Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
February 15, 2018 16:05 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The company...
Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
February 08, 2018 17:25 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial results...
Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4
January 10, 2018 07:57 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of its...